A new method is described for generating recombinant human and chicken antibody fragments for accurate quantification of haptens in solution. The chemistry of labelling small molecules has always been a problem in the development of immunoassays. Here, we describe a specific panning procedure that enables the selection of recombinant anti-idiotypic phage antibodies that bind to hapten binding molecules (e.g., antibodies) in the absence of the hapten, but are displaced in a highly specific and concentration dependent manner, in the presence of the hapten. The major advantage of such a detection system is that there is no need to label the hapten or to covalently attach it to a solid phase. In this study we demonstrate, using cortisol and ald...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The development of antibodies to low molecular weight haptens remains challenging due to both the lo...
Item does not contain fulltextA new method is described for generating recombinant human and chicken...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
Abstract Background Phage-display panning is an integral part of biomedical research. Regular pannin...
Antibody drug development projects require tools for monitoring the concentration of these drug cand...
<div><p>Anti-idiotype monoclonal antibodies represent a class of reagents that are potentially optim...
<p>Antibody drug development projects require tools for monitoring the concentration of these drug c...
Most immunoassays use probes that convert concentrations of analytes into signal intensity. To prepa...
The strategy required for the development of the immunochemical reagents needed for a non-competitiv...
Recently, we constructed a focused antibody library tailored to interact with haptens. High function...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The ability to profile the prevalence and functional activity of endogenous antibodies is of vast cl...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The development of antibodies to low molecular weight haptens remains challenging due to both the lo...
Item does not contain fulltextA new method is described for generating recombinant human and chicken...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
Abstract Background Phage-display panning is an integral part of biomedical research. Regular pannin...
Antibody drug development projects require tools for monitoring the concentration of these drug cand...
<div><p>Anti-idiotype monoclonal antibodies represent a class of reagents that are potentially optim...
<p>Antibody drug development projects require tools for monitoring the concentration of these drug c...
Most immunoassays use probes that convert concentrations of analytes into signal intensity. To prepa...
The strategy required for the development of the immunochemical reagents needed for a non-competitiv...
Recently, we constructed a focused antibody library tailored to interact with haptens. High function...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The ability to profile the prevalence and functional activity of endogenous antibodies is of vast cl...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The development of antibodies to low molecular weight haptens remains challenging due to both the lo...